Global Atherectomy Devices Market Size and Forecast (2025–2033)

Introduction

The global healthcare industry is undergoing a profound transformation, driven by technological innovation and a growing emphasis on minimally invasive procedures. Among the most impactful advancements in vascular medicine is the use of atherectomy devices, which are designed to remove plaque buildup from arteries and restore normal blood flow. As cardiovascular and peripheral arterial diseases continue to rise worldwide, these devices are emerging as a critical therapeutic solution.

According to Renub Research, the Global Atherectomy Devices Market was valued at US$ 1.05 billion in 2024 and is expected to reach US$ 2.21 billion by 2033, expanding at a CAGR of 8.63% during 2025–2033. This robust growth is fueled by increasing cases of peripheral artery disease (PAD), an aging global population, rapid technological advancements, and growing adoption of minimally invasive vascular interventions.

Download Free Sample Report

Atherectomy Devices Market Overview

Atherectomy devices are specialized medical tools used to remove atherosclerotic plaque from blood vessels, primarily in patients suffering from coronary artery disease (CAD) and peripheral artery disease (PAD). Unlike traditional angioplasty or stent placement, atherectomy physically eliminates plaque by cutting, sanding, grinding, or vaporizing it, thereby improving vessel patency and blood circulation.

These procedures are widely preferred because they are less invasive, reduce recovery time, and are particularly effective for patients with heavily calcified or complex arterial lesions where balloon angioplasty alone may be insufficient. Common atherectomy systems include directional, rotational, orbital, and laser atherectomy devices, each offering distinct advantages based on lesion type and location.

As awareness of minimally invasive treatments increases and healthcare infrastructure improves globally, atherectomy devices are becoming an integral part of modern interventional cardiology and vascular surgery.

Key Drivers Fueling Market Growth

Rising Prevalence of Peripheral Artery Disease (PAD)

One of the strongest growth drivers for the atherectomy devices market is the increasing global burden of PAD. Factors such as diabetes, obesity, smoking, hypertension, and aging significantly raise the risk of arterial plaque formation. PAD affects millions of individuals worldwide and often leads to chronic pain, reduced mobility, and, in severe cases, limb amputation.

Atherectomy devices provide an effective solution by restoring blood flow and alleviating symptoms like leg pain and fatigue. Their ability to treat complex lesions has made them a preferred choice in advanced PAD cases.

Technological Advancements in Device Design

Continuous innovation is reshaping the atherectomy landscape. Modern devices offer greater precision, enhanced safety, and improved clinical outcomes. Advanced systems now integrate real-time imaging technologies such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), allowing physicians to visualize arterial blockages more accurately.

Laser, orbital, and rotational atherectomy technologies have significantly reduced vessel trauma while improving plaque removal efficiency. In August 2022, AngioDynamics, Inc. received 510(k) clearance from the U.S. FDA for an expanded indication of its Auryon Atherectomy System, highlighting the pace of regulatory and technological progress in this market.

Shift Toward Minimally Invasive Procedures

Healthcare providers and patients increasingly prefer minimally invasive treatments due to shorter hospital stays, reduced complications, and faster recovery times. Atherectomy fits perfectly into this paradigm, offering effective intervention without the need for open surgery.

This shift is particularly evident in developed healthcare systems, where outpatient vascular procedures are becoming standard practice.

Emerging Market Opportunities

Expansion Across Developing Economies

Emerging regions such as Asia-Pacific, Latin America, and the Middle East are becoming lucrative growth hubs for atherectomy devices. Rapid urbanization, rising disposable incomes, and increasing awareness of cardiovascular health are driving demand for advanced medical technologies.

Government healthcare reforms, improving reimbursement structures, and growing investments in hospital infrastructure are further accelerating market penetration in these regions.

Challenges Limiting Market Adoption

Shortage of Skilled Professionals

Despite technological progress, atherectomy procedures require highly trained operators. The complexity of device handling and procedural precision limits adoption in regions with inadequate training programs. The cost and duration of physician training also remain a barrier to widespread use.

High Cost of Devices and Procedures

Atherectomy systems are technologically advanced and expensive, making them less accessible in low- and middle-income countries. In regions with limited insurance coverage or reimbursement support, the cost of procedures can discourage both providers and patients, restraining market expansion.

Regional Market Insights

North America: Market Leader

North America dominates the global atherectomy devices market due to its advanced healthcare infrastructure, strong reimbursement policies, and high prevalence of cardiovascular diseases. The region’s early adoption of minimally invasive technologies continues to support sustained growth.

United States Atherectomy Devices Market

The U.S. market benefits significantly from an aging population. According to census data released in May 2023, nearly 55.8 million Americans (16.8% of the population) are aged 65 or older. Since PAD and atherosclerosis are more common among the elderly, demand for atherectomy devices continues to rise.

Additionally, lifestyle-related conditions such as high cholesterol and diabetes remain widespread. A May 2024 CDC report indicates that approximately 25 million U.S. adults suffer from high cholesterol, further increasing the need for effective vascular interventions.

Europe: Strong Growth Momentum

Europe holds a substantial share of the atherectomy market, supported by rising cardiovascular disease prevalence and favorable healthcare policies.

Germany Atherectomy Devices Market

Germany’s well-established healthcare system and strong emphasis on minimally invasive treatments are driving market growth. Favorable reimbursement frameworks and technological innovation continue to support the adoption of atherectomy procedures, particularly among the aging population.

Asia-Pacific: Fastest-Growing Region

Asia-Pacific is expected to witness the fastest growth during the forecast period due to population expansion, increasing healthcare spending, and rising cardiovascular disease awareness.

India Atherectomy Devices Market

India’s market is expanding rapidly due to a growing elderly population and increasing prevalence of diabetes, obesity, and PAD. Government initiatives to improve healthcare access and rising adoption of advanced medical technologies are expected to further fuel market growth in the coming years.

Middle East & Africa: Emerging Potential

Saudi Arabia Atherectomy Devices Market

Saudi Arabia is experiencing steady growth due to increased healthcare investments, an aging population, and a rising burden of cardiovascular disease. National healthcare modernization initiatives are encouraging the adoption of advanced vascular technologies, including atherectomy systems.

Market Segmentation Overview

By Product Type

Directional Atherectomy

Rotational Atherectomy

Orbital Atherectomy

Laser Atherectomy

By Application

Cardiovascular

Neurovascular

Peripheral Vascular

By End User

Hospitals

Ambulatory Care Services

Medical Research Institutes

Competitive Landscape

The global atherectomy devices market is highly competitive, with major players focusing on innovation, strategic partnerships, and product expansion. Key companies covered across five analytical viewpoints (overview, key personnel, product portfolio, recent developments, and revenue analysis) include:

Boston Scientific Corporation

Abbott Laboratories

Medtronic plc

Cardinal Health

Terumo Corporation

Integer Holdings Corporation

Becton, Dickinson and Company

AngioDynamics, Inc.

These companies continue to invest heavily in R&D to enhance device efficiency, safety, and clinical outcomes.

Final Thoughts

The Global Atherectomy Devices Market is poised for strong and sustained growth through 2033, driven by rising cardiovascular disease prevalence, technological innovation, and the global shift toward minimally invasive healthcare solutions. While challenges such as high costs and skilled labor shortages remain, expanding healthcare infrastructure and improving awareness—especially in emerging markets—are expected to unlock new growth opportunities.

As healthcare systems worldwide prioritize early intervention and patient-centric treatment approaches, atherectomy devices will continue to play a crucial role in transforming vascular care and improving patient outcomes across the globe.